If equal access to quality cancer care is to be more than an aspiration, we need to define minimum standards. ASCO and ESMO have now taken a lead with a consensus statement.
Related Articles
Editorial
Making rights a reality
Cover Story
Too high or too low? ESMO’s clinical benefit scale fuels debate over approval thresholds
Spotlight on